The largest and fastest-growing subset of Social Security Disability (SSDI) beneficiaries is patients with psychiatric diagnoses, even as the federal SSDI Trust Fund diminishes. In 2005, the Social Security Administration authorized the Mental Health Treatment Study (MHTS) to test the hypothesis that a comprehensive, team-based, supported employment program would increase the likelihood that beneficiaries would find work.
Most medical journals (as well as TCPR) require authors to disclose their affiliations with pharmaceutical companies or other for-profit entities, to help readers assess for any evidence of bias.
Lisa A. Brenner, PhD
University of Colorado, Anschutz Medical Campus, Departments of Psychiatry, Physical Medicine and Rehabilitation, and Neurology
Dr. Brenner has disclosed that she has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Despite the increased attention drawn to TBI, I often hear statements from mental health providers like, “I don’t see anybody in my clinic who has a history of TBI,” or, “People with more severe injuries don’t seek mental health services.”
Long-time editorial board member Ivan Goldberg passed away on November 26, 2013. Dr. Goldberg was a psychopharmacologist in New York and the founder of the Depression Central website and one of the largest psychopharmocology listservs in the world. Dr. Goldberg joined the TCPR editorial board in 2006. He will be missed.
Bret A. Moore, PsyD, ABPP
Board-Certified Clinical Psychologist, San Antonio, TX
Dr. Moore has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Former active duty military and current civilian psychologist Dr Bret Moore provides tips and advice for compassionately and effectively treating returning veterans.
Varenicline (Chantix) is a nicotine partial agonist that is approved by the FDA for smoking cessation. Since July 1, 2009, the FDA has also required a “black box warning” based on postmarketing reports of adverse neuropsychiatric effects.
In November, drug giant Johnson & Johnson (J&J) and its subsidiaries agreed to pay $2.2 billion in fines and fees for wrongdoing related to kickbacks and misbranding of a number of their medications.
1 in 3 Americans were victims of online scams in the past year. Even when you know your patient is being scammed, it is hard to pull them out. We speak with Cathy Wilson about...